عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

Sports Boulevard Foundation Wins King Salman Charter for Architecture, Urbanism Award

Sports Boulevard Foundation Wins King Salman Charter for Architecture, Urbanism Award
TT
TT

Sports Boulevard Foundation Wins King Salman Charter for Architecture, Urbanism Award

Sports Boulevard Foundation Wins King Salman Charter for Architecture, Urbanism Award

The Sports Boulevard Foundation has won the prestigious King Salman Charter for Architecture and Urbanism Award, organized by the Architecture and Design Commission. The award recognizes the project’s excellence in embracing the principles and standards of the charter through the implementation of the design code for the Sports Boulevard.
CEO of the Architecture and Design Commission, Dr. Sumayah Al-Sulaiman, presented the award to CEO of the Sports Boulevard Foundation, Jayne McGivern, during the award's closing ceremony at the King Abdulaziz International Conference Center in Riyadh, SPA reported.
The Sports Boulevard Foundation won the award for its integration of a unique design code and its commitment to applying the code, which balances authenticity and modernity, showcasing innovative and distinct urban outputs.
The award seeks to celebrate and recognize projects that distinguish themselves by embodying the values of the King Salman Charter for Architecture and Urbanism. It aims to contribute to achieving the objectives of the charter and to encourage and motivate entities, practitioners, and students to incorporate the charter’s values into their work, fostering a competitive environment that produces a higher level of urban excellence.
The project applies local identity and Salmani architecture across its various elements, not just in buildings, and has gained the trust of a committee of 30 local and international experts in architecture and design. McGivern also mentioned that the Sports Boulevard project is designed to revolutionize urban planning in Riyadh. The project spans over 135 kilometers and includes more than 4.4 million square meters of green and open spaces, along with up to 50 multi-disciplinary sports facilities with integrated infrastructure.
In 2022, the Sports Boulevard Foundation launched the Design Code for all buildings located on Prince Mohammed bin Salman bin Abdulaziz Al Saud Road, emphasizing the importance of local identity and Salmani architecture, which embodies authenticity and modernity in design. The code aims to create a modern and sustainable environment that enhances the quality of life.
The Sports Boulevard is one of Riyadh’s mega projects launched by the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, on March 19, 2019, and is chaired by Crown Prince Mohammed bin Salman bin Abdulaziz Al Saud. The project is committed to improving the quality of life for the city’s residents and visitors by offering integrated infrastructure, pedestrian pathways, cycling pathways, horse-riding trails, and more.

Most Viewed

 
 
Varieties

FDA Approves First Nasal Spray to Treat Dangerous Allergic Reactions

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
TT
TT

FDA Approves First Nasal Spray to Treat Dangerous Allergic Reactions

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, US, August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights

US health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen.

The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis, The AP reported.

Anaphylaxis occurs when the body's immune system develops a sudden, unexpected reaction to a foreign substance, such as food, insect stings or medications. Common symptoms include hives, swelling, itching, vomiting and difficulty breathing.

The device, marketed as Neffy, could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers. Anaphylaxis sends more than 30,000 people to emergency rooms and results in more than 2,000 hospitalizations and more than 230 deaths in the US each year.

Of the 6 million prescriptions written for auto-injectors each year, more than 40% are never filled, Dr. Thomas Casale, an allergist at the University of South Florida, told an FDA advisory panel last year. Even when they are available to caregivers, many auto-injectors are used incorrectly, he said.

“There’s a real unmet medical need for a large portion of the population,” he said.

Neffy is intended for people who weigh at least 66 pounds. It is given in a single dose sprayed into one nostril. A second dose can be given if the person’s symptoms don’t improve.

The new treatment could be life-changing for people with severe food allergies, said Dr. Kelly Cleary, a pediatrician and director with the Food Allergy Research & Education, a nonprofit advocacy group.

“I have seen the look of worry or fear,” said Cleary, whose 11-year-old son has multiple food allergies. “I worry about what happens if someone hesitates.”

Requiring an injection in an emergency is as scary to some children as the allergic reaction itself. Some parents have had to restrain thrashing children to inject them, sometimes causing cuts that require stitches. About 3,500 caregivers a year are injured when they accidentally inject themselves in the hands, ARS said.

Priscilla Hernandez, of Pasadena, California said her 12-year-old son, Zacky, who is allergic to sesame, peanuts, tree nuts, avocado and other foods, was traumatized when he had a reaction at school about six years ago and a nurse treated him with an auto-injector.

“Having to do a shot creates this whole different level of anxiety,” she said.

She said, “we are over the moon” about the FDA's approval of the spray, which Zacky will start carrying when it becomes available.

First marketed in 1901, epinephrine predates the FDA itself. Products like the EpiPen auto-injector, approved in 1987, were authorized based on chemistry and manufacturing data and were not required to prove safety and efficacy.

Clinical trials of people experiencing potentially deadly reactions are difficult for ethical and pragmatic reasons. Instead, ARS officials compared the effect of the nasal spray on biological markers to existing epinephrine treatments.

Results showed Neffy worked about as well as injected epinephrine to boost heart rate and blood pressure, which counter severe reactions. The drug is combined with a patented agent that allows it to be easily absorbed through nasal membranes.